PT925064E - 5-androsteno-3beta,17alfa-diol como um inibidor do crescimento tumoral - Google Patents

5-androsteno-3beta,17alfa-diol como um inibidor do crescimento tumoral

Info

Publication number
PT925064E
PT925064E PT97920244T PT97920244T PT925064E PT 925064 E PT925064 E PT 925064E PT 97920244 T PT97920244 T PT 97920244T PT 97920244 T PT97920244 T PT 97920244T PT 925064 E PT925064 E PT 925064E
Authority
PT
Portugal
Prior art keywords
androsteno
17alfa
3beta
diol
inhibitor
Prior art date
Application number
PT97920244T
Other languages
English (en)
Inventor
Roger M Loria
Original Assignee
Roger M Loria
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roger M Loria filed Critical Roger M Loria
Publication of PT925064E publication Critical patent/PT925064E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PT97920244T 1996-04-11 1997-04-10 5-androsteno-3beta,17alfa-diol como um inibidor do crescimento tumoral PT925064E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1504296P 1996-04-11 1996-04-11
US1898596P 1996-06-04 1996-06-04

Publications (1)

Publication Number Publication Date
PT925064E true PT925064E (pt) 2003-11-28

Family

ID=26686886

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97920244T PT925064E (pt) 1996-04-11 1997-04-10 5-androsteno-3beta,17alfa-diol como um inibidor do crescimento tumoral

Country Status (8)

Country Link
EP (1) EP0925064B1 (pt)
JP (1) JP2000508643A (pt)
AT (2) ATE311886T1 (pt)
DE (2) DE69723087T2 (pt)
DK (1) DK0925064T3 (pt)
ES (2) ES2254828T3 (pt)
PT (1) PT925064E (pt)
WO (1) WO1997037662A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1362591B1 (en) * 1996-04-11 2005-12-07 LORIA, Roger M. Use of a composition containing 5-androstene-3beta,17alpha-diol
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) * 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
DK1955700T3 (da) 1999-09-30 2011-05-23 Harbor Biosciences Inc Terapeutisk behandling af androgenreceptor-betingede lidelser
AU2001241779A1 (en) 2000-02-25 2001-09-03 Hollis-Eden Pharmaceuticals, Inc. Method of treatment of prostate cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4898694A (en) * 1987-11-25 1990-02-06 Schwartz Arthur G 17-Hydroxy-steroids
US5461042A (en) * 1988-12-30 1995-10-24 Loria; Roger M. Regulation of the immune system
US5206008A (en) * 1991-04-15 1993-04-27 Virginia Commonwealth University Enhancement of immune response
US5478566A (en) * 1993-09-29 1995-12-26 Loria; Roger M. Stimulation of cytokine production

Also Published As

Publication number Publication date
ATE311886T1 (de) 2005-12-15
DE69723087T2 (de) 2004-05-06
ATE243518T1 (de) 2003-07-15
EP0925064A1 (en) 1999-06-30
DK0925064T3 (da) 2003-10-20
EP0925064A4 (en) 2001-11-07
DE60308917D1 (de) 2006-11-16
EP0925064B1 (en) 2003-06-25
DE60308917T2 (de) 2006-12-28
DE69723087D1 (de) 2003-07-31
WO1997037662A1 (en) 1997-10-16
ES2202606T3 (es) 2004-04-01
ES2254828T3 (es) 2006-06-16
JP2000508643A (ja) 2000-07-11

Similar Documents

Publication Publication Date Title
IL87885A (en) Pharmaceutical compositions having antiprogestational and anti-estrogenic activities for the treatment of hormone- dependent tumors
GR3036188T3 (en) Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase
DE3161494D1 (en) Cosmetic preparations
ES2195664T3 (es) Uso de fumaratos de dialquilo.
NO20001583D0 (no) Stimulering av hematopoetiske celler in vitro
AU2789989A (en) Acylated uridine and cytidine and uses thereof
DK0493480T3 (da) Dehydrodidemnin B
PT758248E (pt) Formulacoes para o factor ix
ATE393831T1 (de) Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
DK1082410T3 (da) Humane CD45 - og/eller fibroblast mesenchymale stamceller
MY100641A (en) Neutral metalloendopeptidase inhibitors in the treatment of hypertension.
HK1075467A1 (en) Process for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process
UA70956C2 (uk) Інгібітори стероїдсульфатази
DE69734605D1 (de) Abgeschwächter salmonellenstamm, gebraucht als vehikel zur oralen immunisierung
BR9808858A (pt) Terapias antitumores compreendendo uma combinação de um extrato de cartilagem e um agente antineoplástico provendo uma alta eficácia e baixos efeitos colaterais tóxicos
AR022583A1 (es) Secuencias antitumorales anti-sentido dirigidas contra los componentes r1 y r2 de la reductasa de los ribonucleotidos
DE60137835D1 (de) Modifizierte zytokine für krebs therapie
GB9825096D0 (en) Cells,culture methods and their uses
PT925064E (pt) 5-androsteno-3beta,17alfa-diol como um inibidor do crescimento tumoral
AU4751797A (en) Defined systems for epithelial cell culture and use thereof
WO1998010085A3 (en) Gene therapy for congestive heart failure
DE60327710D1 (de) Modifizierte zytokine für krebs therapie
CA2252110A1 (en) 5-androstene 3.beta.,17.alpha. diol as an inhibitor of tumor growth
TR199802496T2 (xx) Konjestif kalp yetmezli�ini tedavi i�in form�lasyon.
GB9723824D0 (en) Cytostatic agents